Kavita Venkataraman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kavita Venkataraman has a total of 198 co-authors. Here are the top co-authors by number of shared publications:
- E. Shyong Tai
Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
15 shared publications Miyang Luo
Saw Swee Hock School of Public Health, National University Singapore, Singapore, Republic of Singapore
8 shared publicationsTessa Riandini
5 shared publications- Andy Hau Yan Ho
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
4 shared publications - Hwee Lin Wee
Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
4 shared publications - Josip Car
King’s Population Health Institute, King’s College London, London, UK
4 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (10) , 2685-2711
A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes
- 26 August 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (10) , 2685-2711
Open AccessA narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes
- Open Access
- 17 July 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04166
Diabetes-related foot complications and caregiver burden: insights from a cross-sectional study in multi-ethnic Asians
Diabetes mellitus poses a significant healthcare challenge with a predicted rise in the number of affected individuals from 537 million to 783 million by 2045 [1]. Complications from diabetes have a significant impact on morbidity and mortality and can inflict negative effects on patients’ mobility, mental health, socioeconomic status, and quality of life [2–5], causing […]
- 17 July 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04166
Open AccessDiabetes-related foot complications and caregiver burden: insights from a cross-sectional study in multi-ethnic Asians
Diabetes mellitus poses a significant healthcare challenge with a predicted rise in the number of affected individuals from 537 million to 783 million by 2045 [1]. Complications from diabetes have a significant impact on morbidity and mortality and can inflict negative effects on patients’ mobility, mental health, socioeconomic status, and quality of life [2–5], causing […]
- Open Access
- 30 April 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (2) , e004143
Role of social determinants, lifestyle and clinical factors in the development of diabetic peripheral neuropathy among a multiethnic Asian population in Singapore: a retrospective analysis
Introduction: Diabetic peripheral neuropathy (DPN) is a common, underdiagnosed and irreversible complication of diabetes mellitus. However, limited evidence exists on the drivers of DPN in Asian populations, particularly the role of social and lifestyle factors. This study aimed to identify sociodemographic, lifestyle and clinical predictors of incident DPN in a multiethnic Asian cohort in Singapore. Methods: Data from two ongoing Singaporean cohorts were analysed. Participants included individuals with type 2 diabetes mellitus and no DPN at baseline. DPN was assessed at follow-up using self-report, neurothesiometer testing or monofilament scores. Bivariate and multivariate Cox regression analyses were conducted to examine the association between incident DPN and various sociodemographic, lifestyle and clinical factors. Results: During a median follow-up of 3.69 years, 169 out of 2110 participants developed DPN. Multivariable analysis revealed age (HR 1.06, 95% CI 1.04 to 1.08, p<0.001), sedentary time (HR 1.54, 95% CI 1.06 to 2.26, p=0.018), housing (HR 0.67 for larger flats, 95% CI 0.48 to 0.94, p=0.020), HbA1c (HR 1.23, 95% CI 1.14 to 1.32, p<0.001), diabetes duration (HR 1.03, 95% CI 1.02 to 1.05, p<0.001), body mass index (HR 1.04, 95% CI 1.01 to 1.07, p=0.010), systolic (HR 0.99, 95% CI 0.98 to 1.00, p=0.004) and diastolic blood pressure (HR 1.02, 95% CI 1.01 to 1.03, p=0.002) and cardiovascular disease (HR 2.00, 95% CI 1.37 to 2.93, p =0.009) to be independently associated with incident DPN. Conclusions: This study confirms established risk factors for DPN and highlights housing type and sedentary behaviour as novel, potentially modifiable predictors. These findings underscore the importance of targeting high-risk groups and addressing modifiable risk factors to reduce the burden of DPN in Asian populations.
- 30 April 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (2) , e004143
Open AccessRole of social determinants, lifestyle and clinical factors in the development of diabetic peripheral neuropathy among a multiethnic Asian population in Singapore: a retrospective analysis
Introduction: Diabetic peripheral neuropathy (DPN) is a common, underdiagnosed and irreversible complication of diabetes mellitus. However, limited evidence exists on the drivers of DPN in Asian populations, particularly the role of social and lifestyle factors. This study aimed to identify sociodemographic, lifestyle and clinical predictors of incident DPN in a multiethnic Asian cohort in Singapore. Methods: Data from two ongoing Singaporean cohorts were analysed. Participants included individuals with type 2 diabetes mellitus and no DPN at baseline. DPN was assessed at follow-up using self-report, neurothesiometer testing or monofilament scores. Bivariate and multivariate Cox regression analyses were conducted to examine the association between incident DPN and various sociodemographic, lifestyle and clinical factors. Results: During a median follow-up of 3.69 years, 169 out of 2110 participants developed DPN. Multivariable analysis revealed age (HR 1.06, 95% CI 1.04 to 1.08, p<0.001), sedentary time (HR 1.54, 95% CI 1.06 to 2.26, p=0.018), housing (HR 0.67 for larger flats, 95% CI 0.48 to 0.94, p=0.020), HbA1c (HR 1.23, 95% CI 1.14 to 1.32, p<0.001), diabetes duration (HR 1.03, 95% CI 1.02 to 1.05, p<0.001), body mass index (HR 1.04, 95% CI 1.01 to 1.07, p=0.010), systolic (HR 0.99, 95% CI 0.98 to 1.00, p=0.004) and diastolic blood pressure (HR 1.02, 95% CI 1.01 to 1.03, p=0.002) and cardiovascular disease (HR 2.00, 95% CI 1.37 to 2.93, p =0.009) to be independently associated with incident DPN. Conclusions: This study confirms established risk factors for DPN and highlights housing type and sedentary behaviour as novel, potentially modifiable predictors. These findings underscore the importance of targeting high-risk groups and addressing modifiable risk factors to reduce the burden of DPN in Asian populations.
- Open Access
MRMhub: one-stop solution for automated processing of large-scale targeted metabolomics data
Data processing and quality control are essential for complex targeted mass spectrometry (MS) assays in large-scale metabolomics studies. However, existing software solutions have significant gaps in robustness and scalability. We report MRMhub, a one-stop solution for streamlined processing of large-scale targeted MS data. MRMhub consists of a novel peak integration engine with unique algorithmic design to address the scalability challenge and a comprehensive collection of post-acquisition data processing and analytical quality control tools. The ensemble facilitates rapid and consistent processing of complex chromatograms, quantification, drift and batch correction, quality assessment and control, feature filtering, and data/workflow sharing and reporting. MRMhub can process data from highly complex assays in population-scale studies within minutes, with full digital footprints warranting reproducibility and traceability. We demonstrate its performance using two large-scale lipidomics data sets. We distribute the source code and data sets freely for community development.
Open AccessMRMhub: one-stop solution for automated processing of large-scale targeted metabolomics data
Data processing and quality control are essential for complex targeted mass spectrometry (MS) assays in large-scale metabolomics studies. However, existing software solutions have significant gaps in robustness and scalability. We report MRMhub, a one-stop solution for streamlined processing of large-scale targeted MS data. MRMhub consists of a novel peak integration engine with unique algorithmic design to address the scalability challenge and a comprehensive collection of post-acquisition data processing and analytical quality control tools. The ensemble facilitates rapid and consistent processing of complex chromatograms, quantification, drift and batch correction, quality assessment and control, feature filtering, and data/workflow sharing and reporting. MRMhub can process data from highly complex assays in population-scale studies within minutes, with full digital footprints warranting reproducibility and traceability. We demonstrate its performance using two large-scale lipidomics data sets. We distribute the source code and data sets freely for community development.
- 30 July 2025
- Published by Springer Nature in Diabetologia
- p. 1-13
Health economic evaluation of a risk-stratified intervention in diabetic kidney disease
Aims/hypothesis The study aimed to model the progression of diabetic kidney disease (DKD) in a multi-ethnic Asian population and evaluate the economic impact of a risk-stratified intervention for DKD management. Methods Using the Singapore Diabetic Cohort (N=9660), multi-state Markov models were constructed to derive chronic kidney disease (CKD) stage-specific transition probabilities for disease progression based on Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. These were internally validated in 50% training and 50% testing datasets and further validated in national administrative datasets (N=73,256). A cost-effectiveness and budget impact analysis for a hypothetical intervention of sodium–glucose cotransporter 2 inhibitors (SGLT2is) was conducted from a healthcare system perspective, across different time horizons, in low-risk (G0–G2) and high-risk individuals (G3–G4) based on eGFR-defined DKD risk stages. Results Annually, more than half of the participants (53.0–88.8%) stayed in the same DKD stage, with the probabilities of progressing or regressing to the next DKD stage being highest between stages G0 and G1. The SGLT2i intervention was cost-effective when given in low-risk, but not in high-risk, individuals with type 2 diabetes in both the short and the long term. Additionally, implementing the SGLT2i intervention would incur a 5 year cumulative cost increase of 41.5%, assuming an annual 5% increase in market uptake. Conclusions/interpretation We developed a robust model of DKD progression based on real-world data and demonstrated its value through economic modelling of risk-stratified interventions with known effectiveness. This model can aid policymakers and health professionals in evaluating population-level interventions for evidence-based policy decisions. Graphical Abstract
- 30 July 2025
- Published by Springer Nature in Diabetologia
- p. 1-13
Health economic evaluation of a risk-stratified intervention in diabetic kidney disease
Aims/hypothesis The study aimed to model the progression of diabetic kidney disease (DKD) in a multi-ethnic Asian population and evaluate the economic impact of a risk-stratified intervention for DKD management. Methods Using the Singapore Diabetic Cohort (N=9660), multi-state Markov models were constructed to derive chronic kidney disease (CKD) stage-specific transition probabilities for disease progression based on Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. These were internally validated in 50% training and 50% testing datasets and further validated in national administrative datasets (N=73,256). A cost-effectiveness and budget impact analysis for a hypothetical intervention of sodium–glucose cotransporter 2 inhibitors (SGLT2is) was conducted from a healthcare system perspective, across different time horizons, in low-risk (G0–G2) and high-risk individuals (G3–G4) based on eGFR-defined DKD risk stages. Results Annually, more than half of the participants (53.0–88.8%) stayed in the same DKD stage, with the probabilities of progressing or regressing to the next DKD stage being highest between stages G0 and G1. The SGLT2i intervention was cost-effective when given in low-risk, but not in high-risk, individuals with type 2 diabetes in both the short and the long term. Additionally, implementing the SGLT2i intervention would incur a 5 year cumulative cost increase of 41.5%, assuming an annual 5% increase in market uptake. Conclusions/interpretation We developed a robust model of DKD progression based on real-world data and demonstrated its value through economic modelling of risk-stratified interventions with known effectiveness. This model can aid policymakers and health professionals in evaluating population-level interventions for evidence-based policy decisions. Graphical Abstract
- 3 June 2025
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 26 (4) , 659-677
Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus
Diabetic peripheral neuropathy (DPN) is a debilitating complication of diabetes, with limited treatment options. This systematic review consolidates longitudinal studies on the development of DPN, identifying key predictors to inform clinical interventions for DPN prevention. PubMed, Embase, and Cochrane databases were searched for peer-reviewed studies on DPN published before March 2024. Longitudinal studies involving populations with diabetes and investigating sociodemographic, lifestyle, anthropometric, and clinical predictors of DPN were included. Studies with missing data or high risk of bias were excluded. Predictors of DPN were extracted from included studies and recorded in an Excel file. Weighted mean differences (continuous variables) and relative risks (dichotomous variables) were calculated to assess predictors’ significance. Twenty-seven studies analyzing 21 predictors were included. The median sample size and follow-up time were 985 and 72 months respectively. Age, HbA1c, BMI, diabetes duration, and systolic blood pressure were strong positive predictors of incident DPN, highlighting the role of glycemic control, weight management, and blood pressure optimization in reducing DPN risk. Modest associations were found for fasting plasma glucose, smoking, height, weight, waist circumference, sex, use of antihyperlipidemia drugs, and retinopathy. A subgroup analysis demonstrated that these findings were relevant to both Type 1 and Type 2 diabetes. Despite the heterogeneity observed in DPN diagnostic criteria and measurements of predictors across studies, several potentially modifiable risk factors for DPN were identified. These findings can help healthcare providers identify high-risk individuals and implement appropriate preventive measures targeting these factors for reducing the risk of DPN development.
- 3 June 2025
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 26 (4) , 659-677
Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus
Diabetic peripheral neuropathy (DPN) is a debilitating complication of diabetes, with limited treatment options. This systematic review consolidates longitudinal studies on the development of DPN, identifying key predictors to inform clinical interventions for DPN prevention. PubMed, Embase, and Cochrane databases were searched for peer-reviewed studies on DPN published before March 2024. Longitudinal studies involving populations with diabetes and investigating sociodemographic, lifestyle, anthropometric, and clinical predictors of DPN were included. Studies with missing data or high risk of bias were excluded. Predictors of DPN were extracted from included studies and recorded in an Excel file. Weighted mean differences (continuous variables) and relative risks (dichotomous variables) were calculated to assess predictors’ significance. Twenty-seven studies analyzing 21 predictors were included. The median sample size and follow-up time were 985 and 72 months respectively. Age, HbA1c, BMI, diabetes duration, and systolic blood pressure were strong positive predictors of incident DPN, highlighting the role of glycemic control, weight management, and blood pressure optimization in reducing DPN risk. Modest associations were found for fasting plasma glucose, smoking, height, weight, waist circumference, sex, use of antihyperlipidemia drugs, and retinopathy. A subgroup analysis demonstrated that these findings were relevant to both Type 1 and Type 2 diabetes. Despite the heterogeneity observed in DPN diagnostic criteria and measurements of predictors across studies, several potentially modifiable risk factors for DPN were identified. These findings can help healthcare providers identify high-risk individuals and implement appropriate preventive measures targeting these factors for reducing the risk of DPN development.
- Open Access
- 23 August 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 04145
Foot care behaviours and associated factors among patients with type 2 diabetes: A cross-sectional study
Type 2 diabetes mellitus (T2DM) is a highly prevalent chronic disease and the ninth leading cause of mortality worldwide [1]. An estimated 529 million people had diabetes in 2021, with T2DM accounting for approximately 96% of all diabetes cases globally [2]. The prevalence of T2DM is particularly pronounced in Asia, with 60% of people with […]
- 23 August 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 04145
Open AccessFoot care behaviours and associated factors among patients with type 2 diabetes: A cross-sectional study
Type 2 diabetes mellitus (T2DM) is a highly prevalent chronic disease and the ninth leading cause of mortality worldwide [1]. An estimated 529 million people had diabetes in 2021, with T2DM accounting for approximately 96% of all diabetes cases globally [2]. The prevalence of T2DM is particularly pronounced in Asia, with 60% of people with […]
- Open Access
- 21 November 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e52036
Empowering Foot Care Literacy Among People Living With Diabetes and Their Carers With an mHealth App: Protocol for a Feasibility Study
Background: Diabetic foot ulcers (DFUs) cause significant morbidity affecting 19% to 34% of people living with diabetes mellitus. DFUs not only impair quality of life but may also result in limb loss and mortality. Patient education has been advocated to raise awareness of proper foot self-care and the necessity of seeking assistance when a foot wound occurs. Modern technologies, including mobile health (mHealth) interventions such as health apps, bring the potential for more cost-effective and scalable interventions. Objective: This study aims to examine the feasibility and usability of a newly developed mHealth app called Well Feet, which is a diabetes and foot care education app for individuals at risk of developing DFU. Methods: Well Feet was developed using an evidence-based and expert panel cocreation approach to deliver educational content available in 3 languages (ie, English, Chinese, and Malay) via animation videos and a range of additional features, including adaptive learning. A nonrandomized, single-arm feasibility study using a mixed methods approach with a series of validated questionnaires and focus group discussions will be conducted. In total, 40 patients and carers will be recruited from a tertiary hospital diabetes clinic to receive a 1-month mHealth intervention. The primary outcomes are the usability of the app and a qualitative perspective on user experience. Secondary outcomes include changes in foot care knowledge, self-management behaviors, and quality of life. Results: Patient recruitment began in July 2023, and the intervention and data collection will be completed by the end of September 2023. This study has been approved by National Healthcare Group Domain Specific Review Board (2022/00614) on February 10, 2023. The expected results will be published in spring 2024. Conclusions: Through this feasibility study, the Well Feet DFU education app will undergo a comprehensive quantitative and qualitative evaluation of its usability and acceptance for future improvement in its design. With local contextualization, cultural adaptation, and its multilingual functionality, the app addresses a critical aspect of DFU health education and self-management in a multiethnic population. Findings from this study will refine and enhance the features of the app based on user feedback and shape the procedural framework for a subsequent randomized controlled trial to assess the effectiveness of Well Feet. Trial Registration: ClinicalTrials.gov NCT05564728; https://clinicaltrials.gov/study/NCT05564728 International Registered Report Identifier (IRRID): DERR1-10.2196/52036
- 21 November 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e52036
Open AccessEmpowering Foot Care Literacy Among People Living With Diabetes and Their Carers With an mHealth App: Protocol for a Feasibility Study
Background: Diabetic foot ulcers (DFUs) cause significant morbidity affecting 19% to 34% of people living with diabetes mellitus. DFUs not only impair quality of life but may also result in limb loss and mortality. Patient education has been advocated to raise awareness of proper foot self-care and the necessity of seeking assistance when a foot wound occurs. Modern technologies, including mobile health (mHealth) interventions such as health apps, bring the potential for more cost-effective and scalable interventions. Objective: This study aims to examine the feasibility and usability of a newly developed mHealth app called Well Feet, which is a diabetes and foot care education app for individuals at risk of developing DFU. Methods: Well Feet was developed using an evidence-based and expert panel cocreation approach to deliver educational content available in 3 languages (ie, English, Chinese, and Malay) via animation videos and a range of additional features, including adaptive learning. A nonrandomized, single-arm feasibility study using a mixed methods approach with a series of validated questionnaires and focus group discussions will be conducted. In total, 40 patients and carers will be recruited from a tertiary hospital diabetes clinic to receive a 1-month mHealth intervention. The primary outcomes are the usability of the app and a qualitative perspective on user experience. Secondary outcomes include changes in foot care knowledge, self-management behaviors, and quality of life. Results: Patient recruitment began in July 2023, and the intervention and data collection will be completed by the end of September 2023. This study has been approved by National Healthcare Group Domain Specific Review Board (2022/00614) on February 10, 2023. The expected results will be published in spring 2024. Conclusions: Through this feasibility study, the Well Feet DFU education app will undergo a comprehensive quantitative and qualitative evaluation of its usability and acceptance for future improvement in its design. With local contextualization, cultural adaptation, and its multilingual functionality, the app addresses a critical aspect of DFU health education and self-management in a multiethnic population. Findings from this study will refine and enhance the features of the app based on user feedback and shape the procedural framework for a subsequent randomized controlled trial to assess the effectiveness of Well Feet. Trial Registration: ClinicalTrials.gov NCT05564728; https://clinicaltrials.gov/study/NCT05564728 International Registered Report Identifier (IRRID): DERR1-10.2196/52036